Ortoma AB (publ)

OM:ORT B Stock Report

Market Cap: SEK 663.8m

Ortoma Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Fredrik Stromberg

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure5.8yrs

Recent management updates

Recent updates

Investors Will Want Ortoma's (STO:ORT B) Growth In ROCE To Persist

Oct 02
Investors Will Want Ortoma's (STO:ORT B) Growth In ROCE To Persist

Ortoma (STO:ORT B) Might Have The Makings Of A Multi-Bagger

Jun 26
Ortoma (STO:ORT B) Might Have The Makings Of A Multi-Bagger

Ortoma (STO:ORT B) Is In A Good Position To Deliver On Growth Plans

Mar 17
Ortoma (STO:ORT B) Is In A Good Position To Deliver On Growth Plans

Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business

Nov 13
Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business

Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business

Oct 25
Ortoma (STO:ORT B) Is In A Strong Position To Grow Its Business

Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price

Sep 20
Ortoma (STO:ORT B) Is Doing The Right Things To Multiply Its Share Price

We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate

Jun 03
We're Keeping An Eye On Ortoma's (STO:ORT B) Cash Burn Rate

We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth

Dec 09
We Think Ortoma (NGM:ORT B) Can Afford To Drive Business Growth

Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans

Aug 17
Ortoma (NGM:ORT B) Is In A Good Position To Deliver On Growth Plans

CEO

Fredrik Stromberg

less than a year
Tenure

Fredrik Strömberg is Chief Executive Officer of Ortoma AB (publ) from 2025. Fredrik Strömberg, M.Sc. in Industrial Engineering and Management Intl. is an experiened leader with very long experienced in Med...

Leadership Team

NamePositionTenureCompensationOwnership
Tommy Hansson
Chief Medical Officer & Director11.8yrsSEK 219.60k1.61%
SEK 10.7m
Fredrik Stromberg
Chief Executive Officerless than a yearno datano data
Anna Zyla
Head of Operationsless than a yearno datano data
Carianne Nilsson
Head of Sales & Marketing1.8yrsno datano data
Andreas Pettersson
Head of Clinical Operations1.8yrsno datano data
Hassan Nemati
Head of Technical Research1.8yrsno datano data
Fredrik Hedberg
Head of QA/RA1.8yrsno datano data
1.8yrs
Average Tenure

Experienced Management: ORT B's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Tommy Hansson
Chief Medical Officer & Director13.8yrsSEK 219.60k1.61%
SEK 10.7m
Yvonne Martensson
Independent Chairman of the Board3.8yrsSEK 439.20k0.12%
SEK 805.5k
Roy Forslund
Director10.8yrsno data12.17%
SEK 80.8m
Peter Möller
Independent Director7.8yrsno data5.78%
SEK 38.4m
Marie Aabo
Independent Director1.8yrsSEK 114.60kno data
Anders Hahn
Director1.8yrsSEK 1.53mno data
5.8yrs
Average Tenure
69yo
Average Age

Experienced Board: ORT B's board of directors are considered experienced (5.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 10:14
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ortoma AB (publ) is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Klas PalinDNB Carnegie Commissioned Research
Mats HyttingeRedeye